Status:
NOT_YET_RECRUITING
Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA
Lead Sponsor:
Loma Linda University
Conditions:
Iron Deficiency Anemia
Eligibility:
All Genders
1-18 years
Phase:
PHASE4
Brief Summary
Iron Deficiency Anemia (IDA) is a prevalent global health issue affecting a significant proportion of the population, including children. While daily oral iron supplementation is a common approach to ...
Detailed Description
This is a prospective open-label randomized controlled study. Patients will be randomized into two groups, one group (investigational) will receive oral iron every other day (every 48 hours) and the c...
Eligibility Criteria
Inclusion
- Confirmed Iron Deficiency Anemia
- Pediatric patients (1-18 years of age) without regard of gender, race, ethnicity nor language.
- Able and willing to take oral iron (tablet or liquid).
Exclusion
- Pregnant or lactating patients
- Known allergies or intolerance to oral iron formulations
- Concomitant chronic medical conditions affecting iron metabolism
- Short gut syndrome
- Celiac disease
- Inflammatory bowel disease
- Cancer
- Chronic kidney disease
- Blood transfusions in the past 3 months
- IV iron administration in the past 3 months
- Oral iron supplementation in the past 2 weeks
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06550362
Start Date
December 1 2025
End Date
May 1 2026
Last Update
November 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.